Track topics on Twitter Track topics that are important to you
Alizyme is a speciality biopharmaceutical development company, based in Cambridge, UK. We are focused on developing products for the treatment and management of gastrointestinal disorders involving inflammation, such as ulcerative colitis, and motility, such as irritable bowel syndrome, of obesity and related diseases, such as diabetes, and of the gastrointestinal side effects of cancer therapy, such as mucositis.
We have a strong and diversified pipeline of commercially significant and distinct product opportunities with attractive risk profiles and potential investment returns and are well placed to achieve our objective of becoming a leading profitable speciality biopharmaceutical development company.
Phone: 44(0)1223 896000
Fax: 44(0)1223 896001
Alizyme is a drug development company. It develops new products to treat diseases with high unmet medical need and substantial market opportunity. To date it has focussed on obesity and related diseas...
Alizyme is a speciality biopharmaceutical development company, based in Cambridge, UK. We are focused on developing products for the treatment and management of gastrointestinal disorders involving in...
We have published hundreds of Alizyme plc news stories on BioPortfolio along with dozens of Alizyme plc Clinical Trials and PubMed Articles about Alizyme plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alizyme plc Companies in our database. You can also find out about relevant Alizyme plc Drugs and Medications on this site too.
Irritable Bowel Syndrome IBS
Irritable bowel syndrome (IBS) is a common but poorly understood chronic (long-term) condition where the normal functions of the bowel are disrupted. Symptoms of IBS include abdominal pain or discomfort, changes in bowel habits and bloated feelings. ...